This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Expression Genetics, Inc.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Innovations of Ram I Mahato in Gene Delivery Technology.
Introduction
Ram I Mahato is an accomplished inventor based in Murray, Utah. He has made significant contributions to the field of gene delivery technology, particularly through his innovative work on cationic lipopolymers. His research focuses on developing biocompatible agents that can effectively deliver nucleic acids and other bioactive agents to various tissues and organs.
Latest Patents
One of Mahato's notable patents is titled "Cationic lipopolymer as biocompatible gene delivery agent." This invention describes a biodegradable, novel cationic lipopolymer that comprises a branched polyethylenimine (PEI), a cholesterol-derived lipid anchor, and a biodegradable linker. The unique structure allows for efficient transfection of cells, both in vitro and in vivo. An example of this innovative lipopolymer is poly{(ethylene imine)-co-[N-2-aminoethyl)ethylene imine]-co-[N-(N-cholesteryloxycarbonyl-(2-aminoethyl))ethylene imine]} (referred to as "PEACE"). The cationic lipopolymers developed in this patent are particularly useful for drug delivery applications.
Career Highlights
Ram I Mahato is currently associated with Expression Genetics, Inc., where he continues to advance his research in gene delivery systems. His work has garnered attention for its potential applications in medical therapies, particularly in the delivery of nucleic acids.
Collaborations
Mahato has collaborated with notable colleagues, including Sang-Oh Han and Darin Y Furgeson, to further enhance the development and application of his inventions.
Conclusion
Ram I Mahato's innovative work in the field of gene delivery technology exemplifies the potential of cationic lipopolymers in advancing medical treatments. His contributions are paving the way for more effective drug delivery systems that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile